163 related articles for article (PubMed ID: 35132908)
1. Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia.
Conti F; Gottardi F; Moratti M; Belotti T; Ferrari S; Selva P; Bassi M; Zama D; Pession A
Platelets; 2022 Jul; 33(5):801-806. PubMed ID: 35132908
[TBL] [Abstract][Full Text] [Related]
2. Rituximab Unveils Hypogammaglobulinemia and Immunodeficiency in Children with Autoimmune Cytopenia.
Ottaviano G; Marinoni M; Graziani S; Sibson K; Barzaghi F; Bertolini P; Chini L; Corti P; Cancrini C; D'Alba I; Gabelli M; Gallo V; Giancotta C; Giordano P; Lassandro G; Martire B; Angarano R; Mastrodicasa E; Bava C; Miano M; Naviglio S; Verzegnassi F; Saracco P; Trizzino A; Biondi A; Pignata C; Moschese V
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):273-282. PubMed ID: 31377437
[TBL] [Abstract][Full Text] [Related]
3. Maintenence rituximab following induction in autoimmune cytopenias.
Rai MP; Lee EJ; Bussel JB
Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
[TBL] [Abstract][Full Text] [Related]
4. Expanded utilization of rituximab in paediatric cardiac transplant patients.
Kiskaddon AL; Landmesser K; Carapellucci J; Wisotzkey B; Asante-Korang A
J Clin Pharm Ther; 2021 Jun; 46(3):762-766. PubMed ID: 33393702
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology.
Miano M; Ramenghi U; Russo G; Rubert L; Barone A; Tucci F; Farruggia P; Petrone A; Mondino A; Lo Valvo L; Crescenzio N; Bellia F; Olivieri I; Palmisani E; Caviglia I; Dufour C; Fioredda F
Br J Haematol; 2016 Nov; 175(3):490-495. PubMed ID: 27447678
[TBL] [Abstract][Full Text] [Related]
6. Successful Treatment of an Adolescent Male With Severe Refractory Evans Syndrome Using Bortezomib-based Therapy.
Knight T; Ravindranath Y; Callaghan MU
J Pediatr Hematol Oncol; 2020 Mar; 42(2):e110-e113. PubMed ID: 30299351
[TBL] [Abstract][Full Text] [Related]
7. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
Olfat M; Silverman ED; Levy DM
Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib treatment of steroid-refractory Evans syndrome in children.
Beydoun SB; Persaud Y; Lafferty J; Callaghan MU; Savaşan S
Pediatr Blood Cancer; 2020 Dec; 67(12):e28725. PubMed ID: 32969165
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution's Experience.
Jasinski S; Weinblatt ME; Glasser CL
J Pediatr Hematol Oncol; 2017 Aug; 39(6):420-424. PubMed ID: 28267088
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib for Refractory Immune-Mediated Thrombocytopenia Purpura.
Beckman JD; Rollins-Raval MA; Raval JS; Park YA; Mazepa M; Ma A
Am J Ther; 2018; 25(2):e270-e272. PubMed ID: 29293474
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of ITP and AIHA in CVID: A systematic literature review].
Lacombe V; Lozac'h P; Orvain C; Lavigne C; Miot C; Pellier I; Urbanski G
Rev Med Interne; 2019 Aug; 40(8):491-500. PubMed ID: 31101329
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Hbibi M; El Alaoui El Hanafi M; Kasmi Z; Ouair H; Benmiloud S; Ailal F; Hida M; Bousfiha AA
Tunis Med; 2024 Jan; 102(1):1-6. PubMed ID: 38545722
[TBL] [Abstract][Full Text] [Related]
14. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.
Gokcebay DG; Tavil B; Fettah A; Yarali N; Azik FM; Tunc B
Clin Appl Thromb Hemost; 2013; 19(6):663-7. PubMed ID: 22815318
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib for immune thrombocytopenia and autoimmune hemolytic anemia.
Muhsen IN; Alahmari A; Alnahedh M; Alkhudair NA; Samarkandi H; El Fakih R
Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):251-254. PubMed ID: 31202670
[No Abstract] [Full Text] [Related]
17. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of refractory secondary immune thrombocytopenia (antiphospholipid antibody syndrome-associated) with the combination of rituximab and romiplostim at the cost of severe bone pain: A case report and review of literature.
Yassa G; Shakir AR; Jagarlamudi K; Yassa AE
J Oncol Pharm Pract; 2021 Jan; 27(1):253-257. PubMed ID: 32611269
[TBL] [Abstract][Full Text] [Related]
19. How I manage Evans Syndrome and AIHA cases in children.
Miano M
Br J Haematol; 2016 Feb; 172(4):524-34. PubMed ID: 26625877
[TBL] [Abstract][Full Text] [Related]
20. [Recurrent infections in an ITP patient treated with rituximab].
Rosenberg-Bezalel S; Asher I; Sthoeger Z
Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
